Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip.

Autor: Maurissen TL; Roche Pharma Research and Early Development, Cardiovascular, Metabolism, Immunology, Infectious Diseases and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Spielmann AJ; Roche Pharma Research and Early Development, Cardiovascular, Metabolism, Immunology, Infectious Diseases and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Schellenberg G; Roche Pharma Research and Early Development, Cardiovascular, Metabolism, Immunology, Infectious Diseases and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Bickle M; Roche Pharma Research and Early Development, Institute of Human Biology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Vieira JR; Roche Pharma Research and Early Development, Cardiovascular, Metabolism, Immunology, Infectious Diseases and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Lai SY; Roche Pharma Research and Early Development, Cardiovascular, Metabolism, Immunology, Infectious Diseases and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Pavlou G; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Fauser S; Roche Pharma Research and Early Development, Cardiovascular, Metabolism, Immunology, Infectious Diseases and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Westenskow PD; Roche Pharma Research and Early Development, Cardiovascular, Metabolism, Immunology, Infectious Diseases and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kamm RD; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. rdkamm@mit.edu.; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. rdkamm@mit.edu., Ragelle H; Roche Pharma Research and Early Development, Cardiovascular, Metabolism, Immunology, Infectious Diseases and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland. heloise.ragelle@roche.com.

Publikováno v: Nature communications [Nat Commun] 2024 Feb 14; Vol. 15 (1), pp. 1372. Date of Electronic Publication: 2024 Feb 14.

A randomized, controlled, and clinical trial to evaluate the efficacy of electrical vestibular stimulation, compared to a sham control for the management of sleep and autonomic parameters in patients with Parkinson's disease.

Autor: Goothy, Sai Sailesh Kumar¹ dr.saisailesh@gmail.com, Sudhir, Gawarikar², Choudhary, Anita³, Govind, Potey Gajanan⁴, Purohit, Manju^5,6, Pathak, Ashish⁷, Chouhan, Rohit Singh⁸, Khanderao, Mahadik Vijay⁹

Publikováno v: Asian Journal of Medical Sciences. Nov2022, Vol. 13 Issue 11, p203-206. 4p.

Effects of otolithic vestibular stimulation on sleep.

Autor: Woodward S; Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan., Tauber ES, Spielmann AJ, Thorpy MJ

Publikováno v: Sleep [Sleep] 1990 Dec; Vol. 13 (6), pp. 533-7.

A randomized controlled trial to evaluate the efficacy of electrical vestibular nerve stimulation (VeNS), compared to a sham control for the management of sleep in young adults.

Autor: Goothy, Sai Sailesh Kumar, Vijayaraghavan, Rajagopalan, Chakraborty, Hirok

Publikováno v: Journal of Basic & Clinical Physiology & Pharmacology; May2023, Vol. 34 Issue 3, p391-399, 9p

Somnomat: a novel actuated bed to investigate the effect of vestibular stimulation.

Autor: Crivelli, Francesco¹, Omlin, Ximena¹ omlinx@alumni.ethz.ch, Rauter, Georg, Zitzewitz, Joachim, Achermann, Peter², Riener, Robert, von Zitzewitz, Joachim^3,4 (AUTHOR)

Publikováno v: Medical & Biological Engineering & Computing. Jun2016, Vol. 54 Issue 6, p877-889. 13p.